Skip to Main Content

Paper Details

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
Arch Med Sci
9
2023
Author NameAffiliation
Maciej BanachMedical University of Lodz (MUL)
Maciej BanachCardiovascular Research Centre, University of Zielona Gora
Maciej BanachPolish Mother's Memorial Hospital Research Institute (PMMHRI)
Maciej BanachCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine
  • 1 - 4

Datasets